Moderna makes several cost-cutting moves, leans into AI

As the vaccine-maker works toward expanding its approved products, it's prioritizing certain R&D efforts and eliminating others.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 2, 2024 Category: Pharmaceuticals Authors: Hannah Green Source Type: news